{"id":50957,"date":"2022-11-16T18:02:04","date_gmt":"2022-11-16T17:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/"},"modified":"2022-11-16T18:02:04","modified_gmt":"2022-11-16T17:02:04","slug":"axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/","title":{"rendered":"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America"},"content":{"rendered":"
\n

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced it ranked No. 4 on the Deloitte Technology Fast 500<\/a>, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 28th<\/sup> year.\n<\/p>\n

<\/a><\/p>\n

\nCompanies were ranked based on the percentage growth in their revenue from 2018 to 2021. Axonics reported $180.3 million of revenue in fiscal year 2021 compared to $707,000 in fiscal year 2018, representing a growth rate of 25,401%.\n<\/p>\n

\nThis is the second year in a row of Axonics being ranked in the top 5 fastest growing companies in North America. Last year, Axonics ranked<\/a> No. 1 on the 2021 Deloitte Technology Fast 500.\n<\/p>\n

\nRaymond W. Cohen, chief executive officer of Axonics, said, \u201cAxonics is proud to be recognized as one of the fastest growing companies in North America. The strong growth of Axonics is a testament to the mission-driven culture of the company, the dedication of our employees, and our commitment to continuous innovation. We have built a company that values diversity, quality, integrity, and teamwork. We remain focused on increasing awareness for Axonics\u2019 best-in-class incontinence solutions, which have the potential to significantly improve the quality of life for millions of adults with bladder and bowel dysfunction.\u201d\n<\/p>\n

\n\u201cThis year\u2019s Technology Fast 500 list is a true reflection of some of today\u2019s most determined and inspiring pioneers who have prospered by anticipating what\u2019s next, understanding what\u2019s needed to succeed and driving creativity forward,\u201d said Christie Simons, partner, Deloitte & Touche LLP and industry leader for technology, media and telecommunications within Deloitte\u2019s audit and assurance practice. \u201cRepresenting all facets of technology, the winners have shown they not only have the vision but can also expertly manage their companies through rapid growth. We congratulate each winner on their impressive achievements.\u201d\n<\/p>\n

\nAbout the 2022 Deloitte Technology Fast 500<\/b>\n<\/p>\n

\nNow in its 28th year, the Deloitte Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences, fintech, and energy tech companies \u2014 both public and private \u2014 in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2018 to 2021.\n<\/p>\n

\nIn order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company\u2019s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.\n<\/p>\n

\nAbout Axonics<\/b>\n<\/p>\n

\nAxonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 1 on the 2022 Financial Times<\/a> ranking of the 500 fastest growing companies in the Americas and No. 4 on the 2022 Deloitte<\/a> Technology Fast 500.\n<\/p>\n

\nAxonics sacral neuromodulation (SNM) systems provide adults suffering from overactive bladder and\/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company\u2019s best-in-class urethral bulking hydrogel, Bulkamid\u00ae<\/sup>, provides safe and durable symptom relief to women with stress urinary incontinence (SUI). Overactive bladder affects an estimated 87 million adults in the U.S. and Europe, with an additional 40 million adults estimated to suffer from fecal incontinence. SUI affects an estimated 29 million women in the U.S. alone. Axonics\u2019 clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com<\/a>.\n<\/p>\n

\nAbout Deloitte<\/b>\n<\/p>\n

\nDeloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (\u201cDTTL\u201d), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as \u201cDeloitte Global\u201d) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the \u201cDeloitte\u201d name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com\/about<\/a> to learn more about our global network of member firms.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNeil Bhalodkar
\n
Investor Relations
\n
949-336-5293
\n
ir@axonics.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced it ranked No. 4 on the Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, fintech, and energy tech companies … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50957","6":"format-standard","7":"category-industry"},"yoast_head":"\nAxonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced it ranked No. 4 on the Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, fintech, and energy tech companies ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T17:02:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221116005768\/en\/788134\/21\/Axonics_Logo_-_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America\",\"datePublished\":\"2022-11-16T17:02:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/\"},\"wordCount\":759,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005768\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/\",\"name\":\"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005768\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\",\"datePublished\":\"2022-11-16T17:02:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005768\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005768\\\/en\\\/788134\\\/21\\\/Axonics_Logo_-_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/","og_locale":"en_US","og_type":"article","og_title":"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America - Pharma Trend","og_description":"IRVINE, Calif.–(BUSINESS WIRE)–Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced it ranked No. 4 on the Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences, fintech, and energy tech companies ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T17:02:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221116005768\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America","datePublished":"2022-11-16T17:02:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/"},"wordCount":759,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005768\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/","url":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/","name":"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005768\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","datePublished":"2022-11-16T17:02:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221116005768\/en\/788134\/21\/Axonics_Logo_-_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221116005768\/en\/788134\/21\/Axonics_Logo_-_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/axonics-ranked-no-4-on-the-2022-deloitte-technology-fast-500-list-of-the-fastest-growing-companies-in-north-america\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Axonics\u00ae Ranked No. 4 on the 2022 Deloitte Technology Fast 500\u2122 List of the Fastest Growing Companies in North America"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50957"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50957\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}